Adult-Use

American Green and Curaleaf enter five-year grow management contract

American Green has entered into a new, five-year management services agreement with Curaleaf Holdings.

American Green and Curaleaf grow management contract

American Green has entered into a new, five-year management services agreement with Curaleaf Holdings.

America’s second publicly-traded company in the cannabis sector, American Green, and international cannabis product provider for medical and adult-use, Curaleaf, have entered into the agreement for two of Curaleaf’s cultivation facilities in Arizona. 

Premium products

American Green’s premium cannabis is used in various Curaleaf and Select products, including some of their Live Resin offerings. The agreement will give American Green approximately (USD)$2.1m dollars in annual revenue and $10.4m in revenue over the term of the agreement.

Steve Cottrell, president of Curaleaf Arizona, said: “American Green has been a great partner to us and we are looking forward to continuing our relationship with them over the next five years.”

American Green president, David Gwyther, added: “We are proud to extend our relationship with Curaleaf Holdings, Inc. for five years. There is also an opportunity for American Green to continue the agreement for three additional five-year periods after our initial five-year term is up.  We will continue to provide our premium cannabis grown at our “Sweet Virginia” grow and provide the quality customer service that Curaleaf has been accustomed to so we can earn those future agreement extensions.”

American Green, which has a team of professionals in cultivation management, manufacturing, extraction, wholesale, retail, and community outreach, now has more than 50,000 certified beneficial shareholders, and aims to lead the cannabis and premium CBD industry.

[activecampaign form=31]

Topicscannabiscannabis industryCannabis productsinternational

Stephanie Price

Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".

More from Stephanie

Spotted an error, or have a tip? Contact the newsroom.

Up next · Adult-Use

Switzerland’s SCRIPT Trial Finds Regulated Cannabis Sales Change How People Consume, Not How Much

Ben Stevens · 25 September 2026

More